Yahoo
ASX - Delayed Quote AUD

Integral Diagnostics Limited (IDX.AX)

1.7650 -0.0100 (-0.56%)
At close: October 30 at 4:10:11 PM GMT+11
Chart Range Bar
Loading chart for IDX.AX
  • Previous Close 1.7750
  • Open 1.7800
  • Bid 1.7600 x --
  • Ask 1.7650 x --
  • Day's Range 1.6950 - 1.7800
  • 52 Week Range 1.6950 - 2.7100
  • Volume 3,673,263
  • Avg. Volume 1,193,769
  • Market Cap (intraday) 659.575M
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) 29.42
  • EPS (TTM) 0.0600
  • Earnings Date (est.) --
  • Forward Dividend & Yield 0.09 (5.27%)
  • Ex-Dividend Date Aug 28, 2026
  • 1y Target Est 2.67

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It offers medical diagnostic imaging services, such as magnetic resonance imaging, computed tomography, mammography, ultrasound, and radiography, as well as nuclear medicine, including positron emission tomography. The company was founded in 1967 and is headquartered in East Melbourne, Australia.

www.integraldiagnostics.com.au

3,049

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

IDX.AX
27.69%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

IDX.AX
29.09%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

IDX.AX
27.79%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

IDX.AX
56.62%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Analyst Insights

View More

Analyst Price Targets

1.82
2.67 Average
1.7650 Current
3.35 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.78%

  • Return on Assets (ttm)

    3.24%

  • Return on Equity (ttm)

    3.21%

  • Revenue (ttm)

    788.62M

  • Net Income Avi to Common (ttm)

    21.93M

  • Diluted EPS (ttm)

    0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    51.29M

  • Total Debt/Equity (mrq)

    87.62%

  • Levered Free Cash Flow (ttm)

    53.54M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: